Skip to content

Supplier News

Pernix releases Zohydro ER hydrocodone capsules with BeadTek

Pernix releases Zohydro ER hydrocodone capsules with BeadTek

Pernix Therapeutics Holdings Inc. has rolled out a new formulation of Zohydro Extended-Release Capsules (hydrocodone bitartrate, CII) with BeadTek technology, to U.S. pharmacies. Pernix said Monday that Zohydro ER with BeadTek is available in strengths 10 mg, 15 mg, 20 mg, 30 mg, 40 mg and 50 mg.

Coca-Cola announces executive promotions

Coca-Cola announces executive promotions

The Coca-Cola Co. board has promoted a pair of senior executives and elected two new vice presidents. The beverage giant said Thursday that J. Alexander “Sandy” Douglas Jr., currently senior vice president and president of Coca-Cola North America, has been promoted to executive vice president.

Mylan raises bid, Perrigo again rejects

Mylan N.V. has upped its offer to acquire Perrigo Co. plc but received the same response: no. On Wednesday, Mylan announced an increased bid in which Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share, a deal valued at more than $35 billion.

Parata Systems goes live with new website

Parata Systems goes live with new website

Parata Systems has launched a new website that the company said offers a more user-friendly experience. The pharmacy automation and medication management solution provider said Tuesday that the new Parata.

Akorn adds to executive team

Akorn Inc. has announced four appointments to its management team, including a new sales and marketing leader. The specialty generic pharmaceutical company said Monday that Jonathan Kafer has been hired as executive vice president of sales and marketing, a newly created position.

Mylan says no to Teva’s acquisition bid

Mylan N.V. has rejected an unsolicited bid to be acquired by Teva Pharmaceutical Industries Ltd. in a cash-and-stock deal valued at more than $40 billion. Mylan said Monday that its board of directors unanimously voted against Teva’s offer, which was announced on April 21.